Anakinra treatment in drug-resistant Behcet’s disease: a case series

Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet’s disease

(2014) Shigeru Iwata et al.   Modern Rheumatology

Resistant Behçet Disease Responsive to Anakinra

(2013) Costantino Botsios et al.   ANNALS OF INTERNAL MEDICINE

Canakinumab in a patient with juvenile Behçet's syndrome with refractory eye disease: Figure 1

(2012) Serdal Ugurlu et al.   ANNALS OF THE RHEUMATIC DISEASES

Multicenter Study of Infliximab for Refractory Uveoretinitis in Behçet Disease

(2012) Hiroshi Goto   ARCHIVES OF OPHTHALMOLOGY

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

(2012) Charles A. Dinarello et al.   NATURE REVIEWS DRUG DISCOVERY

Adalimumab for the treatment of Behcet's disease: experience in 19 patients

(2012) D. Perra et al.   RHEUMATOLOGY

Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behçet's disease: an open-label pilot study

(2011) Ahmet Gül et al.   ANNALS OF THE RHEUMATIC DISEASES

On-demand anakinra treatment is effective in mevalonate kinase deficiency

(2011) E. J. Bodar et al.   ANNALS OF THE RHEUMATIC DISEASES

Cytokines and Behcet's Disease

(2011) Z.Y. Zhou et al.   AUTOIMMUNITY REVIEWS

The fresco of autoinflammatory diseases from the pediatric perspective

(2011) Donato Rigante   AUTOIMMUNITY REVIEWS

Infliximab for patients with neuro-Behcet's disease: case series and literature review

(2011) Afshin Borhani Haghighi et al.   CLINICAL RHEUMATOLOGY

Favourable and sustained response to anakinra in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with or without AA amyloidosis

(2010) L. Obici et al.   ANNALS OF THE RHEUMATIC DISEASES

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

(2010) P. Quartier et al.   ANNALS OF THE RHEUMATIC DISEASES

Evaluation of current therapeutic strategies in Behçet’s disease

(2010) Iliana Alexoudi et al.   CLINICAL RHEUMATOLOGY

Interferon therapy in rheumatic diseases: state-of-the-art 2010

(2010) Ina Kötter et al.   CURRENT OPINION IN RHEUMATOLOGY

Anti-TNF Agents for Behçet's Disease: Analysis of Published Data on 369 Patients

(2010) Aikaterini Arida et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome

(2009) Bénédicte Neven et al.   ARTHRITIS AND RHEUMATISM

CSF levels of cytokines in neuro-Behçet's disease

(2009) A. Borhani Haghighi et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Adalimumab treatment for life threatening pulmonary artery aneurysm in Behçet disease: a case report

(2009) Sung-Won Lee et al.   CLINICAL RHEUMATOLOGY

Successful switching to adalimumab in an infliximab-allergic patient with severe Behçet disease-related uveitis

(2009) Kaoru Takase et al.   RHEUMATOLOGY INTERNATIONAL

EULAR recommendations for the management of Behcet disease

(2008) G Hatemi et al.   ANNALS OF THE RHEUMATIC DISEASES

Infliximab for the treatment of Neuro-Behçet's disease: A case series and review of the literature

(2008) Nicolò Pipitone et al.   ARTHRITIS AND RHEUMATISM

Interleukin-6 in neuro-Behçet’s disease: Association with disease subsets and long-term outcome

(2008) Gülşen Akman-Demir et al.   CYTOKINE